Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
INTS6
REST API REST API
Homo sapiens
INTS6 is differentially expressed in 271 experiments: 116 organism parts: testis, bone marrow, ... (114 more);, 178 disease states: normal, acute myeloid leukemia, ... (176 more);, 87 cell types 342 cell lines 35 compound treatments and 73 other conditions.
Synonyms DDX26, DICE1, DDX26A, INT6, DBI-1, Notchl2, HDB
Orthologs Ints6 (Mus musculus)   D3ZBC5_RAT (Rattus norvegicus)   ENSCING00000008165 (Ciona intestinalis)   ints6 (Danio rerio)   INTS6 (Gallus gallus)   INTS6 (Bos taurus)   CG3125 (Drosophila melanogaster)   ints6 (Xenopus laevis)   INTS6 (Canis familiaris)   (Compare orthologs)
Gene Ontology Term protein binding, actin cytoskeleton, nucleus, integrator complex, snRNA processing, transmembrane signaling receptor activity
InterPro Term VWF_A
UniProt Accession Q9UL03, C9J0C6, C9J885, C9JAV7, B4E1J5, C9K0V7, C9JVX2, C9JXP6, B4DL13, B3KQH5, F8WBG1, F8WAV7
Search EB-eye ENSG00000102786
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-15765, E-GEOD-6573, E-GEOD-1577, E-GEOD-3526, E-MTAB-62, ... (26 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-5258, E-GEOD-19639, E-GEOD-18005, E-GEOD-2450, ... (38 experiments)

Factor Value U/D Experiments
A549
2
E-GEOD-3202, E-GEOD-6013
DU145
2
E-GEOD-17482, E-GEOD-20089
HCC2157
2
E-MTAB-37, E-MTAB-62
PC3
2
E-GEOD-5258, E-MEXP-2034
MCF-7
1
2
E-GEOD-19639, E-GEOD-20081, E-GEOD-3529
HL-60
1
2
E-GEOD-24147, E-MTAB-37, E-GEOD-5258
336 more value(s).


Cell type

studied in E-GEOD-22373, E-GEOD-21668, E-GEOD-3920, E-GEOD-4219, E-GEOD-20677, ... (40 experiments)

Factor Value U/D Experiments
stromal cell
2
E-MEXP-2034, E-GEOD-1460
B lymphocyte
1
1
E-GEOD-6691
native fetal RPE
1
E-GEOD-18811
adherent cell
1
E-MEXP-551
adult native RPE from 78 y.o. donor
1
E-GEOD-18811
human embryonic stem cell
1
E-GEOD-20033
81 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-15960, E-GEOD-1577, E-MEXP-2280, E-GEOD-16363, ... (55 experiments)

Factor Value U/D Experiments
colorectal carcinoma
2
E-MTAB-37, E-GEOD-23878
colon carcinoma
2
E-MTAB-37, E-GEOD-3726
prostate carcinoma
2
E-MEXP-2034, E-MTAB-62
uterine fibroid
2
E-MTAB-62, E-GEOD-7307
glioblastoma
1
2
E-MTAB-37, E-GEOD-6014, E-MTAB-62
B-cell neoplasm
1
1
E-MTAB-37
172 more value(s).


Compound treatment

studied in E-GEOD-5258, E-GEOD-15205, E-TABM-782, E-TABM-868, E-GEOD-5099, ... (21 experiments)

Factor Value U/D Experiments
none
1
4
E-TABM-782, E-TABM-868, E-GEOD-4600, E-GEOD-995, E-MEXP-1601 ... (5 experiments)
control
2
E-GEOD-3284, E-GEOD-5339
unknown
1
E-GEOD-7307
4-hydroxytamoxifen
2
1
E-MEXP-2241
ethanol
1
E-MEXP-2241
4,5-dianilinophthalimide
2
1
E-GEOD-5258
29 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
DMSO
1
1
E-GEOD-19519
thapsigargin
1
E-GEOD-19519
tunicamycin
1
1
E-GEOD-19519


BioSourceProvider
studied in E-GEOD-19466, E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cancer site
studied in E-GEOD-4271

cd3
studied in E-GEOD-22601

Cell treatment
studied in E-MEXP-1192

Cellular component
studied in E-GEOD-1400

Clinical history
studied in E-GEOD-22097, E-GEOD-19420, E-TABM-234, E-GEOD-19743, E-GEOD-7967, ... (8 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-6710, E-GEOD-19348, E-MEXP-1251, ... (8 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

development stage
studied in E-GEOD-22601

Developmental stage
studied in E-MEXP-2359, E-GEOD-2666, E-GEOD-4667, E-MTAB-62

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-1323, E-GEOD-19743, E-GEOD-3325, E-GEOD-2509, E-GEOD-22148, ... (6 experiments)

Environmental stress
studied in E-GEOD-1643, E-GEOD-1518

Er
studied in E-GEOD-20194, E-GEOD-16716

Estrogen receptor status
studied in E-GEOD-6532

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-8023, E-MTAB-73, E-MEXP-1482, E-GEOD-17385, E-GEOD-20847, ... (8 experiments)

Genotype
studied in E-GEOD-3494, E-GEOD-17476, E-MEXP-421, E-TABM-601, E-GEOD-3790, ... (7 experiments)

Gestation age
studied in E-GEOD-14334

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-GEOD-13073, E-MEXP-1220, E-GEOD-5681, E-GEOD-7011, E-MEXP-2657, ... (11 experiments)

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234

Individual
studied in E-TABM-325, E-MTAB-197, E-TABM-740, E-MEXP-2069, E-MEXP-1648, ... (34 experiments)

Infection
studied in E-GEOD-12108, E-MEXP-561

Injury
studied in E-GEOD-19743

Karyotype
studied in E-GEOD-7214

Labeling
studied in E-LGCL-5

Material type
studied in E-MEXP-1082, E-GEOD-9171

Media
studied in E-MEXP-765

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

Nbefore
studied in E-GEOD-20194, E-GEOD-16716

organ
studied in E-GEOD-24283

Organism
studied in E-GEOD-1801, E-TABM-84

Organism status
studied in E-GEOD-19188

Original diagnosis
studied in E-GEOD-21521

P53 ihc
studied in E-GEOD-21653

Phenotype
studied in E-GEOD-7819, E-GEOD-1309, E-GEOD-21750, E-GEOD-1657, E-GEOD-4600, ... (6 experiments)

Population
studied in E-GEOD-4922, E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-6532

Protocol type
studied in E-GEOD-19445, E-GEOD-19246

pt
studied in E-GEOD-21653

Qpcr egfr dct
studied in E-GEOD-5851

Replicate
studied in E-GEOD-10896

RNAi
studied in E-GEOD-12438, E-MEXP-1509, E-MEXP-101, E-GEOD-3697, E-MEXP-1857 ... (5 experiments)

Sample preparation
studied in E-GEOD-16728, E-GEOD-12710

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743, E-GEOD-17400, E-GEOD-18995

Sex
studied in E-GEOD-7307

Stimulation
studied in E-GEOD-20114

stimulus
studied in E-GEOD-22103

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-3494, E-GEOD-4922, E-GEOD-19188

Transfection
studied in E-GEOD-14680

Translocation cyclin group
studied in E-GEOD-2912

Treatment
studied in E-GEOD-16837, E-GEOD-19246, E-GEOD-12198

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-4290

Tumor size
studied in E-GEOD-8167, E-GEOD-6532

Vehicle
studied in E-GEOD-5258

Processing time: 0.491 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM